CRENESSIFRIENDS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CRENESSIFRIENDS Trademark

Serial Number: 98908360

CRENESSIFRIENDS is a trademark filed by Neurocrine Biosciences, Inc. on December 17, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Neurocrine Biosciences, Inc. (238 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

December 17, 2024

Registration Date

Not Registered

Published for Opposition

January 13, 2026

Goods & Services

Patient support services, namely, insurance consultation on access to medicines; Patient support services, namely, providing financial assistance for pharmaceutical co-pays; patient support services, namely, providing consultation and information on insurance coverage and reimbursement

Printed children's books; printed children's booklets; printed children's activity books; printed newsletters in the field of endocrine diseases and disorders

Patient support services, namely, coordinating the procurement of medications; Patient support services, namely, providing emotional support for patients, caregivers and healthcare providers

Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders; creating an online community for users for the purpose of participating in discussions in the fields of health, pharmaceuticals, and coping strategies

Educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the fields of health and pharmaceuticals and distribution of training material in connection therewith; Educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the fields of congenital adrenal hyperplasia, adrenal insufficiency and endocrine diseases and disorders; education services, namely, providing mentorship programs in the field of health and pharmaceuticals

Promoting public awareness of congenital adrenal hyperplasia by means of discussion of congenital adrenal hyperplasia and coping strategies; Promoting public awareness of adrenal insufficiency by means of discussion of adrenal insufficiency and coping strategies; Promoting public awareness of endocrine diseases and disorders by means of discussion of endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders

Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders; Patient support services, namely, providing medical information and consultation about available resources for patients, caregivers and healthcare providers; Providing medical information at in-person health forums for users participating in discussions in the field of congenital adrenal hyperplasia; Providing medical information at in-person health forums for users participating in discussions in the field of adrenal insufficiency; Providing medical information at in-person health forums for users participating in discussions in the field of endocrine diseases and disorders

Providing an online forum in the field of health and pharmaceuticals

Downloadable children's books; downloadable children's booklets in the fields of health and pharmaceuticals; downloadable children's booklets in the fields of congenital adrenal hyperplasia, adrenal insufficiency and endocrine diseases and disorders; downloadable children's activity books; downloadable electronic newsletters in the fields of health and pharmaceuticals; downloadable electronic newsletters in the fields of congenital adrenal hyperplasia, adrenal insufficiency and endocrine diseases and disorders; downloadable computer software games

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 10, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 15, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 15, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 15, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 15, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 18, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 18, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 6, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2025 COAR
NEW APPLICATION ENTERED
Dec 17, 2024 NWAP